MedPath

HYQVIA

HYQVIA

Approved
DIN Number

02524406

Drug Class

Human

Market Date

Nov 7, 2023

Company
HC

takeda canada inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02524406
AIG Number0263359001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
A
ATC Code
J06BA01 IMMUNOGLOBULINS, NORMAL HUMAN, FOR EXTRAVASC. ADM
Product Specifications
Dosage FormSolution
Route of AdministrationSubcutaneous
AHFS Classification80:04.00
Health Canada Classification

ACTIVE INGREDIENTS (2)

HYALURONIDASE (HUMAN RECOMBINANT)Active
Strength: 2400 UNIT / 15 ML
Monograph: HYALURONIDASE (HUMAN RECOMBINANT)
IMMUNOGLOBULIN (HUMAN)Active
Strength: 30 G / 300 ML
Monograph: IMMUNOGLOBULIN (HUMAN)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.